Keyphrases
Adherence Rate
57%
Artificial Intelligence
23%
Automated Retinal Image Analysis
100%
Clinical Requirements
50%
Confidence Interval
52%
Cost-effectiveness Modeling
50%
Diabetes Diagnosis
23%
Diabetic Retinopathy Screening
85%
Endolaser
50%
Eye Care
40%
Fixation Method
50%
Glaucoma
37%
Haptics
90%
Hypodermic Needle
33%
Image Analysis System
42%
Intranasal Corticosteroids
50%
Intraocular Lens
25%
Intraocular Lens Fixation
25%
Intraocular Lens Tilt
25%
Intrascleral Haptic Fixation
50%
Lens Tilt
50%
Low Risk
29%
Low-income Patients
66%
Meta-analysis
50%
Non-mydriatic
66%
Ocular Changes
50%
Operating Room
25%
Ophthalmic Care
50%
Optics
32%
Patient Demographics
23%
Patients with Diabetes
66%
Phenylephrine
100%
Predilation
29%
Primary Care
50%
Primary Care Setting
57%
Proparacaine
83%
Pupil Size
32%
Pupillary Dilation
55%
Retinal Screening
23%
Scleral-fixated Intraocular Lens
50%
Screening System
30%
Severe Complications
25%
Stent Implantation
50%
Suprachoroidal Hemorrhage
50%
Systematic Meta-analysis
50%
Tropicamide
100%
Vision Threatening
29%
XEN Gel Stent
50%
Yamane
60%
Zeiss
25%
Medicine and Dentistry
Agents Acting on the Eye
50%
Bleeding
50%
Chlordiazepoxide
50%
Clinical Study
25%
Cost-Effectiveness Analysis
50%
Cross Sectional Study
25%
Diabetes
32%
Diabetic Retinopathy
92%
Diagnosis
50%
Eye Care
32%
Fisher Exact Test
12%
Fundus Photography
12%
Glaucoma
50%
Glaucoma Medication
50%
Glaucoma Treatment
25%
Health Care Cost
53%
Image Analysis
100%
Implant
37%
Incisional Glaucoma Surgery
12%
Intraocular Lens
100%
Intraocular Pressure
50%
Isoniazid
25%
Meta-Analysis
50%
Methazolamide
12%
Ocular Anatomy
25%
Operating Room
20%
Patient Population
19%
Patient Referral
25%
Patient with Diabetes
62%
Phenylephrine
50%
Placebo
25%
Primary Health Care
100%
Prospective Cohort Study
12%
Proxymetacaine
39%
Retina Image
100%
Rhinitis
16%
Screening
14%
Student T Test
25%
Study Participant
12%
Subcapsular Cataract
25%
Surgeon
75%
Surgical Approach
25%
Surgical Instrument
25%
Surgical Technique
25%
Systematic Review
50%
Topical Agent
12%
Trabecular Meshwork
25%
Trabeculoplasty
12%
Tropicamide
50%
Visual Impairment
12%
